Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,375.60
-44.80 (-1.85%)
May 29, 2026, 3:29 PM IST
Mankind Pharma Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Mankind Pharma stock has a consensus rating of "Buy" and an average price target of ₹2,653. The average 1-year stock price forecast is 11.69% higher than the current stock price, while the lowest is ₹1,990 (-16.23%) and the highest is ₹3,100 (+30.49%).
Price Target: ₹2,653 (+11.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Mankind Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 8 | 8 | 7 |
| Buy | 5 | 6 | 7 | 8 | 8 | 8 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 2 | 2 | 2 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 18 | 18 | 19 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹2,850 | Buy | Maintains | ₹2,850 | +19.97% | May 22, 2026 |
| Jefferies | Jefferies | Buy Maintains ₹3,000 | Buy | Maintains | ₹3,000 | +26.28% | May 21, 2026 |
| Motilal Oswal | Motilal Oswal | Buy Reiterates ₹2,640 | Buy | Reiterates | ₹2,640 | +11.13% | Apr 29, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.